Testing Nucleo CMP Forte for treating pediatric traumatic brain injuries
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics: A Randomized Controlled Trial
This study is testing if Nucleo CMP Forte can help children with moderate to severe traumatic brain injuries recover better.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Trial ID | NCT04499755 on ClinicalTrials.gov |
What this trial studies
This study evaluates the efficacy of Nucleo CMP Forte in children suffering from moderate to severe traumatic brain injuries. It is a Phase 3 interventional trial that aims to determine how well this treatment works in improving outcomes for pediatric patients. The study will involve administering Nucleo CMP Forte and monitoring its effects on recovery and brain function. The goal is to provide evidence for its effectiveness in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with moderate to severe traumatic brain injuries.
Not a fit: Patients with underlying central nervous system disorders may not benefit from this treatment.
Why it matters
Potential benefit: If successful, this treatment could significantly improve recovery outcomes for children with traumatic brain injuries.
How similar studies have performed: There is limited information on similar studies, making this approach relatively novel in the context of pediatric traumatic brain injury.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with traumatic brain injury: Moderate and Severe. Exclusion Criteria: * Underlying CNS disorders,
Where this trial is running
Tanta
- Sherief Abd-Elsalam — Tanta, Egypt (Recruiting)
Study contacts
- Principal investigator: Abeer Salamah, Lecturer — Pediatrics department - Kafr-Elsheikh University
- Study coordinator: Sherief Abd-Elsalam, ass. prof.
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.